title: High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.
authors.forename: M
authors.initials: M
authors.lastname: Magni
authors.forename: M
authors.initials: M
authors.lastname: Di Nicola
authors.forename: C
authors.initials: C
authors.lastname: Carlo-Stella
authors.forename: P
authors.initials: P
authors.lastname: Matteucci
authors.forename: L
authors.initials: L
authors.lastname: Devizzi
authors.forename: C
authors.initials: C
authors.lastname: Tarella
authors.forename: F
authors.initials: F
authors.lastname: Benedetti
authors.forename: M
authors.initials: M
authors.lastname: Martelli
authors.forename: C
authors.initials: C
authors.lastname: Patti
authors.forename: G
authors.initials: G
authors.lastname: Parvis
authors.forename: A
authors.initials: A
authors.lastname: Rambaldi
authors.forename: T
authors.initials: T
authors.lastname: Barbui
authors.forename: A M
authors.initials: AM
authors.lastname: Gianni
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D033581:Stem Cell Transplantation / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab